Oct 20, 2022
FDA
The new article describes in detail the regulatory requirements to be applied concerning pivotal clinical investigations in terms of clinical evidence for domestic and foreign clinical studies. Table of Contents The Food and Drug Administration (FDA or the Agency),...
Read More
Oct 14, 2022
FDA
The article provides an overview of the regulatory policy related to the Abbreviated 510(k) Program and highlights the key points associated thereto. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of...
Read More
Oct 14, 2022
FDA
The article provides an overview of the regulatory policy for pivotal clinical investigations in terms of design considerations. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products,...
Read More
Oct 11, 2022
FDA
The new article describes in detail the aspects related to establishing the appropriate record for the assurance of the software used in the course of manufacturing activities. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating...
Read More
Oct 11, 2022
FDA
The new article highlights the aspects related to the way the risk related to general wellness products should be determined. Table of Contents The Food and Drug Administration (FDA or the Agency), the US regulating authority in the sphere of healthcare products, has...
Read More
Oct 11, 2022
FDA
The article provides an overview of the existing regulatory requirements related to the abridged processing of applications for medical devices. Table of Contents The Food and Drug Administration (FDA) Philippines, a country’s regulatory agency in the sphere of...
Read More